跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 581 条关于
“APCARL”
全部
581
临床试验
530
药物
14
机构
19
资讯
18
9个月前
Havih Envirosciences Partners with Andhra Pradesh Government to Establish BSL-4 Anti-Infective Drug Development Facility
去年
PEARL Study: Durvalumab Monotherapy Shows Promise in NSCLC Patients with High PD-L1 Expression
去年
Oncolytic Virus and Toripalimab Combination Shows Promise in Acral Melanoma
11个月前
Nasus Pharma Partners with Aptar to Accelerate NS002 Intranasal Epinephrine Development
去年
Elicera Therapeutics Completes Patient Recruitment for ELC-100 Phase I/II Study
去年
Aptar Develops Dual-Active Material Science Technology for GLP-1 Drug Protection
2个月前
Aptar Pharma Launches Integrated System-Level Framework to Support Injectable Drug Development
去年
Aptar Pharma Partners with Dianosic to Develop Novel Bioresorbable Intranasal Drug Delivery Platform
去年
Aptar Launches Clinical Study to Validate SmartTrack™ Platform for Accelerating Generic Inhaler Approvals
12天前
Aptar and Aceso Therapeutics Partner to Advance Inhaled Antisense Oligonucleotide Therapy for Cystic Fibrosis
第 1 页,共 2 页
上一页
下一页